Claure Bets on AI Startup K Health at $900 Million Valuation
- Royalty Pharma founder Pablo Legorreta also invested in round
- New York-based company aims to make primary care accessible
This article is for subscribers only.
K Health, an artificial intelligence company that provides a chatbot to patients before they speak with primary care-focused physicians, raised $50 million in an equity funding round led by Marcelo Claure’s Claure Group, Chief Executive Officer Allon Bloch said in an interview.
Royalty Pharma Plc founder Pablo Legorreta, and existing investors Mangrove Capital Partners, Valor Equity Partners and Atreides Management LP also participated.